<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Public Health</journal-id>
<journal-title>Frontiers in Public Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Public Health</abbrev-journal-title>
<issn pub-type="epub">2296-2565</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpubh.2025.1625461</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Public Health</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Early risk detection of metabolic syndrome using sex-specific machine learning models in military personnel</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname>
<given-names>Wei-Yun</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3064564/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wu</surname>
<given-names>Yi-Syuan</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1509550/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Yen</given-names>
</name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="author-notes" rid="fn0002"><sup>&#x2021;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Tzeng</surname>
<given-names>Wen-Chii</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3061371/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Nursing, Tri-Service General Hospital, National Defense Medical University</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
<aff id="aff2"><sup>2</sup><institution>College of Nursing, National Defense Medical University</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Computer Science and Information Engineering, National Taitung University</institution>, <addr-line>Taitung</addr-line>, <country>Taiwan</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Nursing, Tri-Service General Hospital Songshan Branch</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0003">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2216819/overview">Mohammad Hossein Ebrahimi</ext-link>, Shahroud University of Medical Sciences, Iran</p>
</fn>
<fn fn-type="edited-by" id="fn0004">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2613632/overview">TaChen Chen</ext-link>, Nihon Pharmaceutical University, Japan</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3064144/overview">Gabriela Carrasco</ext-link>, University of Chile, Chile</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Wen-Chii Tzeng, <email>wctzeng@mail.ndmctsgh.edu.tw</email></corresp>
<fn fn-type="equal" id="fn0001"><p><sup>&#x2020;</sup>These authors have contributed equally to this work</p></fn>
<fn fn-type="other" id="fn0002"><p><sup>&#x2021;</sup>ORCID: Yen Huang, <ext-link ext-link-type="uri" xlink:href="https://orcid.org/0009-0006-0744-0254">orcid.org/0009-0006-0744-0254</ext-link></p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>31</day>
<month>10</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>13</volume>
<elocation-id>1625461</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>05</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>10</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Wang, Wu, Huang and Tzeng.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Wang, Wu, Huang and Tzeng</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Metabolic syndrome is a critical predictor of future cardiometabolic disease and an emerging public health concern, particularly in high-demand populations such as military personnel. This study aimed to develop and evaluate sex-specific machine learning models for the early detection of metabolic syndrome using annual health check data. We analyzed records from 179,620 Taiwanese Air Force personnel between 2014 and 2022, incorporating demographic, anthropometric, clinical, lifestyle, mental health, and biochemical variables. Six machine learning algorithms&#x2014;including logistic regression, random forest, K-nearest neighbor, support vector machine, neural network, and na&#x00EF;ve Bayes&#x2014;were trained separately for men and women. Among these models, logistic regression outperformed the others, achieving an accuracy and area under the curve (AUC) of 0.89. Body mass index, age, and alanine aminotransferase levels were consistent predictors across sexes. For men, total cholesterol and uric acid contributed significantly, while hemoglobin and hematocrit were more predictive in women. These findings demonstrate that sex-specific predictive models can support early identification of individuals at high risk for metabolic syndrome, enabling targeted prevention strategies and strengthening population health efforts in military populations and other young to middle-aged adult groups.</p>
</abstract>
<kwd-group>
<kwd>metabolic syndrome</kwd>
<kwd>machine learning</kwd>
<kwd>predictive model</kwd>
<kwd>sex differences</kwd>
<kwd>military personnel</kwd>
<kwd>precision prevention</kwd>
</kwd-group>
<contract-sponsor id="cn1">Ministry of National Defense<named-content content-type="fundref-id">10.13039/501100003559</named-content></contract-sponsor>
<counts>
<fig-count count="3"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="35"/>
<page-count count="13"/>
<word-count count="6573"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Public Health and Nutrition</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<label>1</label>
<title>Introduction</title>
<p>Metabolic syndrome (MetS) is a cluster of interrelated conditions including obesity, elevated blood glucose, dyslipidemia, and hypertension. These conditions frequently co-occur in individuals at increased risk of cardiovascular disease and type 2 diabetes and are strong predictors of morbidity and mortality (<xref ref-type="bibr" rid="ref1">1</xref>). As of 2018, the global prevalence of MetS was estimated at 25% and has since continued to rise, making it a growing public health concern (<xref ref-type="bibr" rid="ref2">2</xref>). Among Air Force personnel, high stress levels increase susceptibility to metabolic disorders (<xref ref-type="bibr" rid="ref3">3</xref>), underscoring the need for early risk detection and targeted prevention strategies in this population.</p>
<p>Numerous factors contribute to MetS, including age, sex (<xref ref-type="bibr" rid="ref3">3</xref>, <xref ref-type="bibr" rid="ref4">4</xref>), chronic disease history (<xref ref-type="bibr" rid="ref5">5</xref>), family history (<xref ref-type="bibr" rid="ref5">5</xref>), and behaviors such as smoking (<xref ref-type="bibr" rid="ref6">6</xref>), alcohol consumption (<xref ref-type="bibr" rid="ref7">7</xref>), betel nut use (<xref ref-type="bibr" rid="ref5">5</xref>), and physical inactivity (<xref ref-type="bibr" rid="ref8">8</xref>). Betel nut chewing is particularly relevant in Asian populations, where its high prevalence and established associations with central obesity, dyslipidemia, and impaired glucose regulation make it a culturally specific conditioning factor in the development of MetS (<xref ref-type="bibr" rid="ref9">9</xref>). Although body mass index (BMI) is frequently used in population screening to identify individuals at risk (<xref ref-type="bibr" rid="ref10">10</xref>), it is not itself a causal determinant of MetS. Instead, the pathophysiological link between MetS and cardiometabolic disease arises from the quantity, distribution, and functionality of adipose tissue, with visceral fat and dysfunctional adipose compartments playing a more critical role than overall body weight (<xref ref-type="bibr" rid="ref11">11</xref>). This distinction underscores the need to interpret BMI cautiously and to consider more direct indicators of body fat and adiposity function in risk assessments. Mental health status (<xref ref-type="bibr" rid="ref12">12</xref>) and biochemical indicators&#x2014;such as white blood cell count, hemoglobin, total cholesterol, alanine aminotransferase (ALT), and uric acid level (<xref ref-type="bibr" rid="ref13">13</xref>, <xref ref-type="bibr" rid="ref14">14</xref>)&#x2014;also show strong associations with MetS risk. While many predictive models have been developed, most rely on traditional statistical methods such as logistic regression and may not fully capture complex interactions among variables.</p>
<p>Machine learning offers a data-driven alternative capable of analyzing high-dimensional health data and identifying nonlinear patterns (<xref ref-type="bibr" rid="ref15">15</xref>). It has shown promise in disease prediction across various health domains. This study focuses on six widely used machine learning algorithms: logistic regression (LR), random forest (RF), K-nearest neighbor (KNN), support vector machine (SVM), neural network (NN), and na&#x00EF;ve Bayes (NB) (<xref ref-type="bibr" rid="ref16">16</xref>, <xref ref-type="bibr" rid="ref17">17</xref>). Each algorithm varies in structure and learning mechanism, providing different strengths in predictive modeling (<xref ref-type="bibr" rid="ref18">18</xref>&#x2013;<xref ref-type="bibr" rid="ref20">20</xref>).</p>
<p>Despite increasing interest in machine learning for health prediction (<xref ref-type="bibr" rid="ref21">21</xref>), its application to MetS risk detection in military populations remains underexplored. This study aims to evaluate the predictive accuracy of multiple machine learning models for MetS using annual health check data from Taiwanese Air Force personnel. We further examine how sex-specific models may enhance prediction by identifying distinct risk profiles in men and women. Our goal is to inform early detection and personalized prevention strategies, contributing to improved metabolic health and operational readiness in high-demand populations.</p>
</sec>
<sec sec-type="materials|methods" id="sec2">
<label>2</label>
<title>Materials and methods</title>
<sec id="sec3">
<label>2.1</label>
<title>Study design and cohort</title>
<p>This population-based study used data from the Taiwanese Military Health Management Information System, which collects annual worksite health examination data from active-duty personnel. We included Air Force members aged 18 to 58&#x202F;years who underwent health screenings between 2014 and 2022. Data included demographic characteristics, anthropometric measures, medical history, lifestyle behaviors, mental health indicators, and biochemical parameters. All procedures followed the ethical standards of the 1975 Declaration of Helsinki and were approved by the Institutional Review Board of Tri-Service General Hospital, Taiwan (approval number: A202305142).</p>
</sec>
<sec id="sec4">
<label>2.2</label>
<title>Measures</title>
<p>We initially examined 36 features potentially associated with MetS (<xref ref-type="bibr" rid="ref22">22</xref>), grouped into three categories: (1) demographic and anthropometric; (2) clinical, lifestyle, and mental health; and (3) biochemical.</p>
<sec id="sec5">
<label>2.2.1</label>
<title>Step 1: demographic and anthropometric features</title>
<p>Age, sex, waist circumference, and BMI were included. BMI was calculated as weight (kg) divided by height squared (m<sup>2</sup>).</p>
</sec>
<sec id="sec6">
<label>2.2.2</label>
<title>Step 2: clinical, lifestyle, and mental health features</title>
<p>Clinical features included history of chronic disease, family history, and blood pressure (systolic and diastolic). Lifestyle features included smoking, betel nut use, alcohol consumption, physical activity, rapid fatigue during exercise, infection within 1&#x202F;month, and regular medication use. The mental health features&#x2014;insomnia, depression, hostility, anxiety, interpersonal sensitivity, and suicidal ideation&#x2014;were assessed using the Brief Symptom Rating Scale-5 (BSRS-5), a validated five-item scale scored on a 5-point Likert scale (0&#x2013;4) (<xref ref-type="bibr" rid="ref23">23</xref>, <xref ref-type="bibr" rid="ref24">24</xref>). Higher scores indicated poorer psychological well-being. The Cronbach&#x2019;s <italic>&#x03B1;</italic> value for the BSRS-5 ranges from 0.77 to 0.90 (<xref ref-type="bibr" rid="ref23">23</xref>).</p>
</sec>
<sec id="sec7">
<label>2.2.3</label>
<title>Step 3: biochemical features</title>
<p>Biochemical features included liver function markers&#x2014;aspartate aminotransferase (AST) and alanine aminotransferase (ALT); renal function markers&#x2014;blood urea nitrogen (BUN) and creatinine; hematological parameters&#x2014;red blood cell (RBC) count, white blood cell (WBC) count, hemoglobin, hematocrit, and platelet count; and cardiovascular indicators&#x2014;total cholesterol (TC), uric acid (UA), triglycerides, high-density lipoprotein cholesterol level (HDL-C), low-density lipoprotein cholesterol (LDL-C), and fasting plasma glucose. The Air Force personnel fasted overnight before venous blood collection. Samples were processed using a clinical chemistry analyzer (ADVIA1800, Siemens, United States).</p>
</sec>
</sec>
<sec id="sec8">
<label>2.3</label>
<title>Study outcomes</title>
<p>The study outcome was the occurrence of MetS during a 9-year surveillance period. MetS diagnosis followed the modified National Cholesterol Education Program Adult Treatment Panel III criteria, with modifications from the International Diabetes Federation, which accounts for waist circumference norms in the Asian population (<xref ref-type="bibr" rid="ref25">25</xref>). Individuals meeting three or more of the following criteria were diagnosed with MetS (<xref ref-type="bibr" rid="ref4">4</xref>): triglycerides &#x2265;150&#x202F;mg/dL, fasting plasma glucose &#x2265;100&#x202F;mg/dL, HDL-C&#x202F;&#x003C;&#x202F;40&#x202F;mg/dL (men) or &#x003C;50&#x202F;mg/dL (women), systolic blood pressure &#x2265;130&#x202F;mmHg or diastolic blood pressure &#x2265;85&#x202F;mmHg, and waist circumference &#x2265;90&#x202F;cm (men) or &#x2265;80&#x202F;cm (women).</p>
<p>Because triglycerides, fasting plasma glucose, HDL-C, blood pressure, and waist circumference were used to define the MetS outcome, these variables were not included as predictors in the machine learning models to avoid circularity and redundancy. In addition, the BSRS total score overlapped with its five individual items, which were retained to provide more granular information. Therefore, seven features were excluded, and the remaining 29 features were retained for model development using the sequential three-step process described above (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Process of data collection and machine learning. MetS, metabolic syndrome.</p>
</caption>
<graphic xlink:href="fpubh-13-1625461-g001.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Flowchart detailing the selection process of Air Force personnel for a study. Step 1 involves demographic and anthropometric features, Step 2 covers clinical, lifestyle, and mental health features, and Step 3 includes biochemical features. The total population is divided into individuals with metabolic syndrome (MetS), 25,007, and those without, 154,613. Eighty percent are used for the training dataset, comprising 20,006 with MetS and 123,690 without. The remaining twenty percent forms the test dataset, consisting of 5,001 with MetS and 30,923 without.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec9">
<label>2.4</label>
<title>Machine learning</title>
<p>A total of 29 key features of MetS were included in the models in three sequential steps (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The contribution of each feature to model performance was evaluated. The dataset was divided into MetS and non-MetS groups at an 80:20 ratio, yielding training and test datasets of 143,696 and 35,924 Air Force personnel, respectively. To address class imbalance, the synthetic minority oversampling technique (SMOTE) was applied exclusively to the training dataset prior to model development, while the test dataset was left unchanged to ensure unbiased evaluation (<xref ref-type="bibr" rid="ref26">26</xref>). For comparison, we also assessed two other approaches, adaptive synthetic sampling (ADASYN) and class weighting, both of which produced area under the receiver operating characteristic curve (AUC) values similar to those obtained with SMOTE (see <xref rid="SM1" ref-type="supplementary-material">Supplementary Table S1</xref> for detailed results). Because SMOTE is well validated and widely applied in biomedical prediction research, it was selected as the primary method for handling class imbalance in this study.</p>
<p>Data preprocessing included standardization to ensure compatibility across models. Six machine learning algorithms&#x2014;KNN, RF, LR, SVM, NN, and NB&#x2014;were implemented via Python (version 3.8) with libraries including scikit-learn, imbalanced-learn, and SHapley Additive exPlanations (SHAP). Each model was initially trained with default hyperparameters, followed by optimization through grid search.</p>
<p>Hyperparameter optimization was conducted using grid search with 5-fold cross-validation for the RF, SVM, and NN models, whereas KNN, LR, and NB were implemented with standard or default configurations. For RF, the grid included variations in the number of trees, maximum depth, and minimum split size; for SVM, the penalty parameter (<italic>C</italic>) and kernel coefficient (<italic>gamma</italic>) were tuned with the RBF kernel; and for NN, hidden layer sizes, regularization (<italic>alpha</italic>), and learning rate were explored. The detailed parameter ranges for all models are provided in <xref rid="SM1" ref-type="supplementary-material">Supplementary Table S2</xref>.</p>
<p>Model performance was evaluated via multiple metrics, including accuracy, F1 score, precision, recall, specificity, and area under the receiver operating characteristic curve (AUC). Accuracy was calculated via the following equation: true positives (TP)&#x202F;+&#x202F;true negatives (TN) / (TP&#x202F;+&#x202F;false negatives [FN]&#x202F;+&#x202F;false positives [FP]&#x202F;+&#x202F;TN)&#x202F;=&#x202F;(TP&#x202F;+&#x202F;TN) / total sample count. The F1 score is the harmonic mean of precision and sensitivity. The precision was calculated as follows: TP / (TP&#x202F;+&#x202F;FP). Recall was calculated as follows: TP / (TP&#x202F;+&#x202F;FN). The specificity was calculated as follows: TN / (FP&#x202F;+&#x202F;TN).</p>
<p>The discriminatory ability of the models was visualized via receiver operating characteristic (ROC) curves. Feature importance was assessed via SHAP values, which provided insights into the top predictors for MetS in the male and female subgroups. These analyses identified the 10 most influential features for each subgroup, providing tailored insights into risk patterns.</p>
</sec>
<sec id="sec10">
<label>2.5</label>
<title>Statistical analysis</title>
<p>Continuous variables are presented as means and standard deviations; categorical variables are shown as frequencies and percentages. Group comparisons between individuals with and without MetS were conducted using independent <italic>t</italic>-tests for continuous data and chi-square tests for categorical data. A <italic>p</italic>-value &#x003C;0.05 indicated statistical significance.</p>
</sec>
</sec>
<sec sec-type="results" id="sec11">
<label>3</label>
<title>Results</title>
<sec id="sec12">
<label>3.1</label>
<title>Cohort characteristics</title>
<p>The study included 179,620 active-duty Air Force personnel, of whom 83.5% were men. <xref ref-type="table" rid="tab1">Table 1</xref> summarizes the cohort characteristics. A total of 25,007 individuals (13.9%) met the criteria for MetS, whereas 154,613 (86.1%) did not. Individuals in the MetS group were significantly older than those in the non-MetS group (mean age: 34.36&#x202F;&#x00B1;&#x202F;5.94 vs. 29.88&#x202F;&#x00B1;&#x202F;6.79&#x202F;years; <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001). The proportion of men was also greater in the MetS group than in the non-MetS group (95.3% vs. 81.5%; <italic>p</italic>&#x202F;&#x003C;&#x202F;0.001). Mental health scores, excluding those for suicide attempts, were significantly higher in the MetS group. In addition, all biochemical measurements were significantly greater in the MetS group than in the non-MetS group.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Demographic, anthropometric, disease, lifestyle, mental health, and biochemical features of the study cohort (<italic>N</italic>&#x202F;=&#x202F;179,620).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top" rowspan="3">Variable</th>
<th align="center" valign="top" rowspan="2">Total</th>
<th align="center" valign="top" colspan="4">Metabolic syndrome</th>
<th align="center" valign="top" rowspan="3">t/&#x03C7;<sup>2</sup></th>
<th align="center" valign="top" rowspan="3"><italic>p</italic> value</th>
</tr>
<tr>
<th align="center" valign="top" colspan="2">Yes (<italic>n</italic>&#x202F;=&#x202F;25,007)</th>
<th align="center" valign="top" colspan="2">No (<italic>n</italic>&#x202F;=&#x202F;154,613)</th>
</tr>
<tr>
<th align="center" valign="top">Mean (<italic>SD</italic>) or <italic>n</italic> (%)</th>
<th align="center" valign="top">Mean (SD)</th>
<th align="center" valign="top"><italic>n</italic> (%)</th>
<th align="center" valign="top">Mean (SD)</th>
<th align="center" valign="top"><italic>n</italic> (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" colspan="8">Demographic features</td>
</tr>
<tr>
<td align="left" valign="top">Age</td>
<td align="center" valign="top">30.51 (6.85)</td>
<td align="center" valign="top">34.36 (5.94)</td>
<td/>
<td align="center" valign="top">29.88 (6.79)</td>
<td/>
<td align="center" valign="top">&#x2212;108.40</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Sex</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">2947.08</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Women</td>
<td align="center" valign="top">29,720 (16.5)</td>
<td/>
<td align="center" valign="top">1,178 (4.7)</td>
<td/>
<td align="center" valign="top">28,542 (18.5)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Men</td>
<td align="center" valign="top">149,900 (83.5)</td>
<td/>
<td align="center" valign="top">23,829 (95.3)</td>
<td/>
<td align="center" valign="top">126,071 (81.5)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top" colspan="8">Anthropometric feature</td>
</tr>
<tr>
<td align="left" valign="top">Body mass index</td>
<td align="center" valign="top">24.87 (3.79)</td>
<td align="center" valign="top">29.14 (3.35)</td>
<td/>
<td align="center" valign="top">24.18 (3.39)</td>
<td/>
<td align="center" valign="top">&#x2212;216.78</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top" colspan="8">Clinical features</td>
</tr>
<tr>
<td align="left" valign="top">Chronic disease</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">2198.08</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">164,163 (91.4)</td>
<td/>
<td align="center" valign="top">20,926 (83.7)</td>
<td/>
<td align="center" valign="top">143,237 (92.6)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">15,457 (8.6)</td>
<td/>
<td align="center" valign="top">4,081 (16.3)</td>
<td/>
<td align="center" valign="top">11,376 (7.4)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Family history</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">1766.32</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">141,104 (78.6)</td>
<td/>
<td align="center" valign="top">17,114 (68.4)</td>
<td/>
<td align="center" valign="top">123,990 (80.2)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">38,516 (21.4)</td>
<td/>
<td align="center" valign="top">7,893 (31.6)</td>
<td/>
<td align="center" valign="top">30,623 (19.8)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top" colspan="8">Lifestyle features</td>
</tr>
<tr>
<td align="left" valign="top">Smoking</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">1743.10</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">138,496 (77.1)</td>
<td/>
<td align="center" valign="top">16,708 (66.8)</td>
<td/>
<td align="center" valign="top">121,788 (78.8)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">41,124 (22.9)</td>
<td/>
<td align="center" valign="top">8,299 (33.2)</td>
<td/>
<td align="center" valign="top">32,825 (21.2)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Betel nut chewing</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">1558.71</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">171,078 (95.2)</td>
<td/>
<td align="center" valign="top">22,585 (90.3)</td>
<td/>
<td align="center" valign="top">148,493 (96.0)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">8,542 (4.8)</td>
<td/>
<td align="center" valign="top">2,422 (9.7)</td>
<td/>
<td align="center" valign="top">6,120 (4.0)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Alcohol consumption</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">630.12</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">166,262 (92.6)</td>
<td/>
<td align="center" valign="top">22,181 (88.7)</td>
<td/>
<td align="center" valign="top">144,081 (93.2)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">13,358 (7.4)</td>
<td/>
<td align="center" valign="top">2,826 (11.3)</td>
<td/>
<td align="center" valign="top">10,532 (6.8)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Physical activity</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">274.18</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">7,573 (4.2)</td>
<td/>
<td align="center" valign="top">950 (3.8)</td>
<td/>
<td align="center" valign="top">6,623 (4.3)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Occasionally</td>
<td align="center" valign="top">50,196 (27.9)</td>
<td/>
<td align="center" valign="top">7,971 (31.9)</td>
<td/>
<td align="center" valign="top">42,225 (27.3)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">1 to 2 times a week</td>
<td align="center" valign="top">71,180 (39.6)</td>
<td/>
<td align="center" valign="top">9,813 (39.2)</td>
<td/>
<td align="center" valign="top">61,367 (39.7)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">3 to 4 times a week</td>
<td align="center" valign="top">50,671 (28.2)</td>
<td/>
<td align="center" valign="top">6,273 (25.1)</td>
<td/>
<td align="center" valign="top">44,398 (28.7)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Rapid fatigue during exercise</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">2142.28</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">164,477 (91.6)</td>
<td/>
<td align="center" valign="top">21,012 (84.0)</td>
<td/>
<td align="center" valign="top">143,465 (92.8)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">15,143 (8.4)</td>
<td/>
<td align="center" valign="top">3,995 (16.0)</td>
<td/>
<td align="center" valign="top">11,148 (7.2)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Infection within 1&#x202F;month</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">3.24</td>
<td align="center" valign="top">0.072</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">179,266 (99.8)</td>
<td/>
<td align="center" valign="top">24,946 (99.8)</td>
<td/>
<td align="center" valign="top">154,320 (99.8)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">354 (0.2)</td>
<td/>
<td align="center" valign="top">61 (0.2)</td>
<td/>
<td align="center" valign="top">293 (0.2)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Regular medication use</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">142.20</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">No</td>
<td align="center" valign="top">175,403 (97.7)</td>
<td/>
<td align="center" valign="top">24,155 (96.6)</td>
<td/>
<td align="center" valign="top">151,248 (97.8)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Yes</td>
<td align="center" valign="top">4,217 (2.3)</td>
<td/>
<td align="center" valign="top">852 (3.4)</td>
<td/>
<td align="center" valign="top">3,365 (2.2)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top" colspan="8">Mental health features</td>
</tr>
<tr>
<td align="left" valign="top">Total BSRS score</td>
<td align="center" valign="top">0.94 (1.93)</td>
<td align="center" valign="top">1.16 (2.11)</td>
<td/>
<td align="center" valign="top">0.91 (1.90)</td>
<td/>
<td align="center" valign="top">&#x2212;17.81</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">BSRS-1 Sleep score</td>
<td align="center" valign="top">0.27 (0.55)</td>
<td align="center" valign="top">0.35 (0.61)</td>
<td/>
<td align="center" valign="top">0.26 (0.54)</td>
<td/>
<td align="center" valign="top">&#x2212;20.45</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">BSRS-2 Tension score</td>
<td align="center" valign="top">0.19 (0.45)</td>
<td align="center" valign="top">0.22 (0.48)</td>
<td/>
<td align="center" valign="top">0.18 (0.44)</td>
<td/>
<td align="center" valign="top">&#x2212;11.03</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">BSRS-3 Anger score</td>
<td align="center" valign="top">0.20 (0.48)</td>
<td align="center" valign="top">0.26 (0.54)</td>
<td/>
<td align="center" valign="top">0.19 (0.47)</td>
<td/>
<td align="center" valign="top">&#x2212;17.83</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">BSRS-4 Mood score</td>
<td align="center" valign="top">0.16 (0.43)</td>
<td align="center" valign="top">0.19 (0.47)</td>
<td/>
<td align="center" valign="top">0.15 (0.42)</td>
<td/>
<td align="center" valign="top">&#x2212;13.28</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">BSRS-5 Inferiority score</td>
<td align="center" valign="top">0.12 (0.39)</td>
<td align="center" valign="top">0.15 (0.42)</td>
<td/>
<td align="center" valign="top">0.12 (0.38)</td>
<td/>
<td align="center" valign="top">&#x2212;9.31</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Suicide attempt score</td>
<td align="center" valign="top">0.02 (0.15)</td>
<td align="center" valign="top">0.02 (0.16)</td>
<td/>
<td align="center" valign="top">0.02 (0.15)</td>
<td/>
<td align="center" valign="top">&#x2212;3.73</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top" colspan="8">Biochemical features</td>
</tr>
<tr>
<td align="left" valign="top">Aspartate transaminase level</td>
<td align="center" valign="top">20.60 (12.92)</td>
<td align="center" valign="top">26.04 (16.23)</td>
<td/>
<td align="center" valign="top">19.72 (12.07)</td>
<td/>
<td align="center" valign="top">&#x2212;59.00</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Alanine transaminase level</td>
<td align="center" valign="top">24.77 (21.91)</td>
<td align="center" valign="top">41.49 (30.58)</td>
<td/>
<td align="center" valign="top">22.07 (18.82)</td>
<td/>
<td align="center" valign="top">&#x2212;97.50</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Blood urea nitrogen level</td>
<td align="center" valign="top">13.00 (3.10)</td>
<td align="center" valign="top">13.14 (3.28)</td>
<td/>
<td align="center" valign="top">12.97 (3.06)</td>
<td/>
<td align="center" valign="top">&#x2212;7.69</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Creatinine level</td>
<td align="center" valign="top">0.90 (0.20)</td>
<td align="center" valign="top">0.94 (0.30)</td>
<td/>
<td align="center" valign="top">0.89 (0.18)</td>
<td/>
<td align="center" valign="top">&#x2212;27.27</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Red blood cell count</td>
<td align="center" valign="top">5.15 (0.53)</td>
<td align="center" valign="top">5.35 (0.50)</td>
<td/>
<td align="center" valign="top">5.12 (0.52)</td>
<td/>
<td align="center" valign="top">&#x2212;66.36</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">White blood cell count</td>
<td align="center" valign="top">6.67 (1.67)</td>
<td align="center" valign="top">7.51 (1.82)</td>
<td/>
<td align="center" valign="top">6.53 (1.60)</td>
<td/>
<td align="center" valign="top">&#x2212;79.81</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Hemoglobin level</td>
<td align="center" valign="top">15.00 (1.35)</td>
<td align="center" valign="top">15.55 (1.16)</td>
<td/>
<td align="center" valign="top">14.91 (1.35)</td>
<td/>
<td align="center" valign="top">&#x2212;77.80</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Hematocrit level</td>
<td align="center" valign="top">44.67 (3.55)</td>
<td align="center" valign="top">45.99 (3.08)</td>
<td/>
<td align="center" valign="top">44.46 (3.57)</td>
<td/>
<td align="center" valign="top">&#x2212;71.25</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Platelet count</td>
<td align="center" valign="top">261.24 (54.93)</td>
<td align="center" valign="top">271.87 (56.68)</td>
<td/>
<td align="center" valign="top">259.52 (54.45)</td>
<td/>
<td align="center" valign="top">&#x2212;32.13</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Total cholesterol level</td>
<td align="center" valign="top">179.33 (33.80)</td>
<td align="center" valign="top">193.83 (36.06)</td>
<td/>
<td align="center" valign="top">176.99 (32.83)</td>
<td/>
<td align="center" valign="top">&#x2212;69.34</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Uric acid level</td>
<td align="center" valign="top">6.24 (1.44)</td>
<td align="center" valign="top">7.13 (1.45)</td>
<td/>
<td align="center" valign="top">6.10 (1.38)</td>
<td/>
<td align="center" valign="top">&#x2212;104.49</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Low-density lipoprotein cholesterol level</td>
<td align="center" valign="top">111.57 (30.64)</td>
<td align="center" valign="top">122.97 (31.92)</td>
<td/>
<td align="center" valign="top">109.73 (30.03)</td>
<td/>
<td align="center" valign="top">61.39</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top" colspan="8">MetS components</td>
</tr>
<tr>
<td align="left" valign="top">Waist circumference</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">43082.98</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Normal</td>
<td align="center" valign="top">131,192 (73.0)</td>
<td/>
<td align="center" valign="top">4,751 (19.0)</td>
<td/>
<td align="center" valign="top">126,441 (81.8)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Abnormal</td>
<td align="center" valign="top">48,428 (27.0)</td>
<td/>
<td align="center" valign="top">20,256 (81.0)</td>
<td/>
<td align="center" valign="top">28,172 (18.2)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Triglyceride level</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">57528.45</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Normal</td>
<td align="center" valign="top">146,281 (81.4)</td>
<td/>
<td align="center" valign="top">6,684 (26.7)</td>
<td/>
<td align="center" valign="top">139,597 (90.3)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Abnormal</td>
<td align="center" valign="top">33,339 (18.6)</td>
<td/>
<td align="center" valign="top">18,323 (73.3)</td>
<td/>
<td align="center" valign="top">15,016 (9.7)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">High-density lipoprotein cholesterol level</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">35089.92</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Normal</td>
<td align="center" valign="top">147,856 (82.3)</td>
<td/>
<td align="center" valign="top">10,099 (40.4)</td>
<td/>
<td align="center" valign="top">137,757 (89.1)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Abnormal</td>
<td align="center" valign="top">31,764 (17.7)</td>
<td/>
<td align="center" valign="top">14,908 (59.6)</td>
<td/>
<td align="center" valign="top">16,856 (10.9)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Blood pressure</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">30075.96</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Normal</td>
<td align="center" valign="top">127,733 (71.1)</td>
<td/>
<td align="center" valign="top">6,251 (25.0)</td>
<td/>
<td align="center" valign="top">121,482 (78.6)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Abnormal</td>
<td align="center" valign="top">51,887 (28.9)</td>
<td/>
<td align="center" valign="top">18,756 (75.0)</td>
<td/>
<td align="center" valign="top">33,131 (21.4)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Fasting plasma glucose level</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="top">27410.06</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Normal</td>
<td align="center" valign="top">149,090 (83.0)</td>
<td/>
<td align="center" valign="top">11,633 (46.5)</td>
<td/>
<td align="center" valign="top">137,457 (88.9)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Abnormal</td>
<td align="center" valign="top">30,530 (17.0)</td>
<td/>
<td align="center" valign="top">13,374 (53.5)</td>
<td/>
<td align="center" valign="top">17,156 (11.1)</td>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="top">Waist circumference (cm)</td>
<td align="center" valign="top">82.42 (10.44)</td>
<td align="center" valign="top">94.31 (8.24)</td>
<td/>
<td align="center" valign="top">80.50 (9.44)</td>
<td/>
<td align="center" valign="top">&#x2212;240.82</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Triglyceride level (mg/dL)</td>
<td align="center" valign="top">108.13 (74.75)</td>
<td align="center" valign="top">205.95(107.13)</td>
<td/>
<td align="center" valign="top">92.31 (53.27)</td>
<td/>
<td align="center" valign="top">&#x2212;164.49</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">High-density lipoprotein cholesterol level (mg/dL)</td>
<td align="center" valign="top">51.31 (11.87)</td>
<td align="center" valign="top">40.57 (8.11)</td>
<td/>
<td align="center" valign="top">53.05 (11.46)</td>
<td/>
<td align="center" valign="top">211.68</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Systolic blood pressure</td>
<td align="center" valign="top">120.77 (12.66)</td>
<td align="center" valign="top">132.37 (11.78)</td>
<td/>
<td align="center" valign="top">118.90 (11.76)</td>
<td/>
<td align="center" valign="top">&#x2212;167.82</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Diastolic blood pressure</td>
<td align="center" valign="top">73.46 (10.25)</td>
<td align="center" valign="top">82.47 (10.30)</td>
<td/>
<td align="center" valign="top">72.00 (9.47)</td>
<td/>
<td align="center" valign="top">&#x2212;150.80</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="top">Fasting plasma glucose</td>
<td align="center" valign="top">93.32 (12.32)</td>
<td align="center" valign="top">102.84 (22.20)</td>
<td/>
<td align="center" valign="top">91.78 (8.93)</td>
<td/>
<td align="center" valign="top">&#x2212;77.77</td>
<td align="center" valign="top">&#x003C;0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>SD, standard deviation; BSRS, Brief Symptom Rating Scale.</p>
</table-wrap-foot>
</table-wrap>
<p>The chi-square test revealed sex-specific patterns in the prevalence of MetS and its component abnormalities (<xref ref-type="table" rid="tab2">Table 2</xref>). Among men, the most common abnormality was elevated blood pressure (32.9%), followed by increased waist circumference (28.4%), elevated triglycerides (21.3%), hyperglycemia (19.0%), and reduced HDL-C (17.6%). In women, increased waist circumference was most prevalent (19.9%), followed by reduced HDL-C (17.9%), elevated blood pressure (8.9%), hyperglycemia (7.0%), and elevated triglycerides (5.0%).</p>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Sex-specific prevalence of metabolic syndrome by its component abnormality of the cohort study (<italic>N</italic>&#x202F;=&#x202F;179,620).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top" rowspan="2">Metabolic components abnormality</th>
<th align="center" valign="top" colspan="3">Men</th>
<th align="center" valign="top" colspan="3">Women</th>
<th align="center" valign="top" rowspan="2"><italic>p</italic></th>
</tr>
<tr>
<th align="center" valign="top">Total (<italic>N</italic> = 149,900)<break/>n (%)</th>
<th align="center" valign="top">MetS (<italic>N</italic> = 23,829)<break/>n (%)</th>
<th align="center" valign="top">Non-MetS (<italic>N</italic> = 126,071)<break/>n (%)</th>
<th align="center" valign="top">Total (<italic>N</italic> = 29,720)<break/>n (%)</th>
<th align="center" valign="top">MetS (<italic>N</italic> =&#x202F;1,178)<break/>n (%)</th>
<th align="center" valign="top">Non-MetS (<italic>N</italic> = 28,542)<break/>n (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top" rowspan="2">Increased waist circumference</td>
<td align="center" valign="top">42,509 (28.4)</td>
<td align="center" valign="top">19,191 (80.5)</td>
<td align="center" valign="top">23,318 (18.5)</td>
<td align="center" valign="top">5,919 (19.9)</td>
<td align="center" valign="top">1,065 (90.4)</td>
<td align="center" valign="top">4,854 (17.0)</td>
<td align="center" valign="top" rowspan="2">&#x003C;0.001</td>
</tr>
<tr>
<td align="center" valign="top" colspan="3"><italic>p</italic> &#x003C;&#x202F;0.001</td>
<td align="center" valign="top" colspan="3"><italic>p</italic> &#x003C;&#x202F;0.001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">Elevated triglycerides</td>
<td align="center" valign="top">31,854 (21.3)</td>
<td align="center" valign="top">17,698 (74.3)</td>
<td align="center" valign="top">14,156 (11.2)</td>
<td align="center" valign="top">1,485 (5.0)</td>
<td align="center" valign="top">625 (53.1)</td>
<td align="center" valign="top">860 (3.0)</td>
<td align="center" valign="top" rowspan="2">&#x003C;0.001</td>
</tr>
<tr>
<td align="center" valign="top" colspan="3"><italic>p</italic> &#x003C;&#x202F;0.001</td>
<td align="center" valign="top" colspan="3"><italic>p</italic> &#x003C;&#x202F;0.001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">Reduced HDL-C</td>
<td align="center" valign="top">26,444 (17.6)</td>
<td align="center" valign="top">13,928 (58.4)</td>
<td align="center" valign="top">12,516 (9.9)</td>
<td align="center" valign="top">5,320 (17.9)</td>
<td align="center" valign="top">980 (83.2)</td>
<td align="center" valign="top">4,340 (15.2)</td>
<td align="center" valign="top" rowspan="2">0.284</td>
</tr>
<tr>
<td align="center" valign="top" colspan="3"><italic>p</italic> &#x003C;&#x202F;0.001</td>
<td align="center" valign="top" colspan="3"><italic>p</italic> &#x003C;&#x202F;0.001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">Elevated blood pressure</td>
<td align="center" valign="top">49,246 (32.9)</td>
<td align="center" valign="top">18,109 (76.0)</td>
<td align="center" valign="top">31,137 (24.7)</td>
<td align="center" valign="top">2,641 (8.9)</td>
<td align="center" valign="top">647 (54.9)</td>
<td align="center" valign="top">1,994 (7.0)</td>
<td align="center" valign="top" rowspan="2">&#x003C;0.001</td>
</tr>
<tr>
<td align="center" valign="top" colspan="3"><italic>p</italic> &#x003C;&#x202F;0.001</td>
<td align="center" valign="top" colspan="3"><italic>p</italic> &#x003C;&#x202F;0.001</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="2">Hyperglycemia</td>
<td align="center" valign="top">28,456 (19.0)</td>
<td align="center" valign="top">12,777 (53.6)</td>
<td align="center" valign="top">15,679 (12.4)</td>
<td align="center" valign="top">2,074 (7.0)</td>
<td align="center" valign="top">597 (50.7)</td>
<td align="center" valign="top">1,477 (5.2)</td>
<td align="center" valign="top" rowspan="2">&#x003C;0.001</td>
</tr>
<tr>
<td align="center" valign="top" colspan="3"><italic>p</italic> &#x003C;&#x202F;0.001</td>
<td align="center" valign="top" colspan="3"><italic>p</italic> &#x003C;&#x202F;0.001</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>MetS, metabolic syndrome; HDL-C, high density lipoprotein cholesterol.</p>
</table-wrap-foot>
</table-wrap>
<p>When examining the prevalence of MetS within each abnormality, men with increased waist circumference (80.5%), elevated blood pressure (76.0%), or elevated triglycerides (74.3%) were most likely to meet MetS criteria, followed by reduced HDL-C (58.4%) and hyperglycemia (53.6%). In women, increased waist circumference (90.4%) and reduced HDL-C (83.2%) were the strongest correlates of MetS, followed by elevated blood pressure (54.9%), elevated triglycerides (53.1%), and hyperglycemia (50.7%).</p>
<p>Overall, 17.6% of men and 17.9% of women presented with reduced HDL-C (<italic>p</italic> =&#x202F;0.284), indicating no significant sex difference in overall prevalence. However, when stratified by MetS status, reduced HDL-C was observed in 58.4% of men with MetS versus 9.9% without MetS, and in 83.2% of women with MetS versus 15.2% without MetS. These findings suggest that while the overall prevalence of reduced HDL-C was comparable between sexes, within the MetS subgroup, women were disproportionately more likely than men to exhibit reduced HDL-C.</p>
</sec>
<sec id="sec13">
<label>3.2</label>
<title>Model performance</title>
<p>The six machine learning models demonstrated accuracies ranging from 0.80 to 0.89. Among them, the RF, LR, SVM, and NN models achieved the highest overall accuracy (0.89). The NN model had the highest F1 score (0.51), indicating balanced performance in precision and recall. The SVM model had the highest precision (0.73), followed by RF (0.68), LR (0.67), NN (0.65), KNN (0.57), and NB (0.37) models. The model recall values ranged from 0.31 to 0.56, and the specificity values ranged from 0.84 to 0.98 (<xref ref-type="table" rid="tab3">Table 3</xref>).</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>Model performance in predicting MetS.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Model</th>
<th align="center" valign="top">Accuracy</th>
<th align="center" valign="top">F1 score</th>
<th align="center" valign="top">Precision</th>
<th align="center" valign="top">Recall</th>
<th align="char" valign="top" char="&#x00D7;">Specificity</th>
<th align="center" valign="top">AUC</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">K-nearest neighbor</td>
<td align="center" valign="top">0.87</td>
<td align="center" valign="top">0.41</td>
<td align="center" valign="top">0.57</td>
<td align="center" valign="top">0.32</td>
<td align="center" valign="top">0.96</td>
<td align="center" valign="top">0.80</td>
</tr>
<tr>
<td align="left" valign="top">Random forest</td>
<td align="center" valign="top">0.89</td>
<td align="center" valign="top">0.47</td>
<td align="center" valign="top">0.68</td>
<td align="center" valign="top">0.36</td>
<td align="center" valign="top">0.97</td>
<td align="center" valign="top">0.89</td>
</tr>
<tr>
<td align="left" valign="top">Logistic regression</td>
<td align="center" valign="top">0.89</td>
<td align="center" valign="top">0.49</td>
<td align="center" valign="top">0.67</td>
<td align="center" valign="top">0.38</td>
<td align="center" valign="top">0.97</td>
<td align="center" valign="top">0.89</td>
</tr>
<tr>
<td align="left" valign="top">Support vector machine</td>
<td align="center" valign="top">0.89</td>
<td align="center" valign="top">0.44</td>
<td align="center" valign="top">0.73</td>
<td align="center" valign="top">0.31</td>
<td align="center" valign="top">0.98</td>
<td align="center" valign="top">0.84</td>
</tr>
<tr>
<td align="left" valign="top">Neural network</td>
<td align="center" valign="top">0.89</td>
<td align="center" valign="top">0.51</td>
<td align="center" valign="top">0.65</td>
<td align="center" valign="top">0.43</td>
<td align="center" valign="top">0.96</td>
<td align="center" valign="top">0.89</td>
</tr>
<tr>
<td align="left" valign="top">Na&#x00EF;ve Bayes</td>
<td align="center" valign="top">0.80</td>
<td align="center" valign="top">0.44</td>
<td align="center" valign="top">0.37</td>
<td align="center" valign="top">0.56</td>
<td align="center" valign="top">0.84</td>
<td align="center" valign="top">0.81</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>MetS, metabolic syndrome; AUC, area under the receiver operating characteristic curve.</p>
</table-wrap-foot>
</table-wrap>
<p>For predicting MetS events, the LR, RF, and NN models yielded the highest AUC values (all rounded to 0.89), followed by SVM (0.84), NB (0.81), and KNN (0.80; <xref ref-type="fig" rid="fig2">Figure 2</xref>). Pairwise comparisons using DeLong&#x2019;s test indicated that LR achieved the highest AUC (0.894), significantly exceeding RF (0.890; &#x0394;AUC&#x202F;=&#x202F;0.004; p_FDR&#x202F;&#x003C;&#x202F;0.001) and NN (0.873; &#x0394;AUC&#x202F;=&#x202F;0.021; p_FDR&#x202F;&#x003C;&#x202F;0.001; <xref ref-type="table" rid="tab4">Table 4</xref>). RF also significantly outperformed NN (&#x0394;AUC&#x202F;=&#x202F;0.017; p_FDR&#x202F;&#x003C;&#x202F;0.001). The overall performance ranking was LR&#x202F;&#x003E;&#x202F;RF&#x202F;&#x003E;&#x202F;SVM&#x202F;&#x003E;&#x202F;NN, with all four significantly outperformed NN and NB (all p_FDR&#x202F;&#x003C;&#x202F;0.001). Although the absolute AUC differences among LR, RF, and NN were small (&#x2264;0.021), they remained statistically significant after multiple-comparison adjustment.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Receiver operating characteristic (ROC) curves of six machine learning models for predicting metabolic syndrome, with Logistic Regression achieving the highest AUC (0.894), followed by Random Forest, SVM, and Neural Network.</p>
</caption>
<graphic xlink:href="fpubh-13-1625461-g002.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Receiver Operating Characteristic (ROC) curves compare the performance of six classifiers: KNN (AUC = 0.80), Random Forest (AUC = 0.89), Logistic Regression (AUC = 0.89), SVM (AUC = 0.84), Neural Network (AUC = 0.89), and Naive Bayes (AUC = 0.81). The x-axis represents the false positive rate, and the y-axis represents the true positive rate. A diagonal dashed line indicates random classification performance.</alt-text>
</graphic>
</fig>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption>
<p>Pairwise comparison of area under the receiver operating characteristic curve values among six machine learning models for predicting metabolic syndrome using DeLong&#x2019;s test.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Model A</th>
<th align="left" valign="top">Model B</th>
<th align="center" valign="top">AUC A</th>
<th align="center" valign="top">AUC B</th>
<th align="center" valign="top">&#x0394;AUC</th>
<th align="center" valign="top">Z</th>
<th align="center" valign="top">p_FDR_BH</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Logistic Regression</td>
<td align="left" valign="middle">Naive Bayes</td>
<td align="center" valign="middle">0.894</td>
<td align="center" valign="middle">0.818</td>
<td align="center" valign="middle">0.076</td>
<td align="center" valign="middle">38.268</td>
<td align="center" valign="middle">0</td>
</tr>
<tr>
<td align="left" valign="middle">KNN</td>
<td align="left" valign="middle">Logistic Regression</td>
<td align="center" valign="middle">0.818</td>
<td align="center" valign="middle">0.894</td>
<td align="center" valign="middle">&#x2212;0.076</td>
<td align="center" valign="middle">35.574</td>
<td align="center" valign="middle">2.65E-276</td>
</tr>
<tr>
<td align="left" valign="middle">Random Forest</td>
<td align="left" valign="middle">Naive Bayes</td>
<td align="center" valign="middle">0.890</td>
<td align="center" valign="middle">0.818</td>
<td align="center" valign="middle">0.071</td>
<td align="center" valign="middle">35.505</td>
<td align="center" valign="middle">2.06E-275</td>
</tr>
<tr>
<td align="left" valign="middle">KNN</td>
<td align="left" valign="middle">Random Forest</td>
<td align="center" valign="middle">0.818</td>
<td align="center" valign="middle">0.890</td>
<td align="center" valign="middle">&#x2212;0.072</td>
<td align="center" valign="middle">34.004</td>
<td align="center" valign="middle">7.27E-253</td>
</tr>
<tr>
<td align="left" valign="middle">KNN</td>
<td align="left" valign="middle">SVM</td>
<td align="center" valign="middle">0.818</td>
<td align="center" valign="middle">0.882</td>
<td align="center" valign="middle">&#x2212;0.064</td>
<td align="center" valign="middle">30.554</td>
<td align="center" valign="middle">1.52E-204</td>
</tr>
<tr>
<td align="left" valign="middle">SVM</td>
<td align="left" valign="middle">Naive Bayes</td>
<td align="center" valign="middle">0.882</td>
<td align="center" valign="middle">0.818</td>
<td align="center" valign="middle">0.064</td>
<td align="center" valign="middle">28.313</td>
<td align="center" valign="middle">6.03E-176</td>
</tr>
<tr>
<td align="left" valign="middle">KNN</td>
<td align="left" valign="middle">Neural Network</td>
<td align="center" valign="middle">0.818</td>
<td align="center" valign="middle">0.873</td>
<td align="center" valign="middle">&#x2212;0.055</td>
<td align="center" valign="middle">24.271</td>
<td align="center" valign="middle">8.50E-130</td>
</tr>
<tr>
<td align="left" valign="middle">Naive Bayes</td>
<td align="left" valign="middle">Neural Network</td>
<td align="center" valign="middle">0.818</td>
<td align="center" valign="middle">0.873</td>
<td align="center" valign="middle">&#x2212;0.055</td>
<td align="center" valign="middle">23.474</td>
<td align="center" valign="middle">1.42E-121</td>
</tr>
<tr>
<td align="left" valign="middle">Logistic Regression</td>
<td align="left" valign="middle">Neural Network</td>
<td align="center" valign="middle">0.894</td>
<td align="center" valign="middle">0.873</td>
<td align="center" valign="middle">0.021</td>
<td align="center" valign="middle">16.416</td>
<td align="center" valign="middle">2.44E-60</td>
</tr>
<tr>
<td align="left" valign="middle">Random Forest</td>
<td align="left" valign="middle">Neural Network</td>
<td align="center" valign="middle">0.890</td>
<td align="center" valign="middle">0.873</td>
<td align="center" valign="middle">0.017</td>
<td align="center" valign="middle">13.053</td>
<td align="center" valign="middle">9.11E-39</td>
</tr>
<tr>
<td align="left" valign="middle">Logistic Regression</td>
<td align="left" valign="middle">SVM</td>
<td align="center" valign="middle">0.894</td>
<td align="center" valign="middle">0.882</td>
<td align="center" valign="middle">0.012</td>
<td align="center" valign="middle">11.970</td>
<td align="center" valign="middle">6.99E-33</td>
</tr>
<tr>
<td align="left" valign="middle">SVM</td>
<td align="left" valign="middle">Neural Network</td>
<td align="center" valign="middle">0.882</td>
<td align="center" valign="middle">0.873</td>
<td align="center" valign="middle">0.009</td>
<td align="center" valign="middle">8.694</td>
<td align="center" valign="middle">4.38E-18</td>
</tr>
<tr>
<td align="left" valign="middle">Random Forest</td>
<td align="left" valign="middle">SVM</td>
<td align="center" valign="middle">0.890</td>
<td align="center" valign="middle">0.882</td>
<td align="center" valign="middle">0.007</td>
<td align="center" valign="middle">7.515</td>
<td align="center" valign="middle">6.58E-14</td>
</tr>
<tr>
<td align="left" valign="middle">Random Forest</td>
<td align="left" valign="middle">Logistic Regression</td>
<td align="center" valign="middle">0.890</td>
<td align="center" valign="middle">0.894</td>
<td align="center" valign="middle">&#x2212;0.004</td>
<td align="center" valign="middle">4.890</td>
<td align="center" valign="middle">1.08E-06</td>
</tr>
<tr>
<td align="left" valign="middle">KNN</td>
<td align="left" valign="middle">Naive Bayes</td>
<td align="center" valign="middle">0.818</td>
<td align="center" valign="middle">0.818</td>
<td align="center" valign="middle">0.0002</td>
<td align="center" valign="middle">0.059</td>
<td align="center" valign="middle">0.953</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>KNN, k-nearest neighbors; SVM, support vector machine; AUC, area under the receiver operating characteristic curve; &#x0394;AUC, difference in AUC between models; Z, test statistic; p_FDR_BH, <italic>p</italic>-value adjusted for multiple comparisons using the Benjamini&#x2013;Hochberg false discovery rate method.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec14">
<label>3.3</label>
<title>Sex-specific MetS predictors</title>
<p>All six models passed the Hosmer&#x2013;Lemeshow test, indicating good model fit. The top 10 predictive features for MetS identified by SHAP analysis are shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>. Across the entire cohort, BMI, age, ALT level, hemoglobin, and uric acid were the five most strongly predictive features (<xref ref-type="fig" rid="fig3">Figures 3a</xref>,<xref ref-type="fig" rid="fig3">b</xref>). Features related to clinical, lifestyle, and mental health contributed minimally to the prediction. For men, BMI, age, ALT level, total cholesterol, and uric acid level were the most influential predictors (<xref ref-type="fig" rid="fig3">Figures 3c</xref>,<xref ref-type="fig" rid="fig3">d</xref>). For women, BMI, age, hemoglobin, ALT level, and hematocrit were the most predictive features (<xref ref-type="fig" rid="fig3">Figures 3e</xref>,<xref ref-type="fig" rid="fig3">f</xref>). Across both sexes, BMI, age, and ALT levels were consistently identified as the most influential predictors.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p><bold>(a)</bold> Feature importance in the overall model. <bold>(b)</bold> Shapley Additive exPlanations (SHAP) on the overall model output. <bold>(c)</bold> Feature importance in the model for men. <bold>(d)</bold> SHAP on model output for men. <bold>(e)</bold> Feature importance in the model for women. <bold>(f)</bold> SHAP on model output for women.</p>
</caption>
<graphic xlink:href="fpubh-13-1625461-g003.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Chart (a) shows a bar graph ranking features by their SHAP values impacting model output, with BMI and age having the highest impact. Chart (b) is a violin plot displaying the SHAP values for each feature, indicating their effect on the model with a color gradient representing feature values from low to high. Bar chart (c) shows feature importance values with BMI, age, and ALT as the top factors. Beeswarm plot (d) illustrates SHAP values for features like BMI and age, indicating their impact on a model with color gradient representing feature values from low to high. Bar chart and SHAP summary plot. The bar chart shows feature importance, with BMI having the highest score, followed by age, hemoglobin, and others. The SHAP plot visualizes feature impact on the model, indicating BMI as the most significant factor with variations in impact across the features measured from negative to positive SHAP values.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec15">
<label>4</label>
<title>Discussion</title>
<p>Maintaining optimal health in military personnel is crucial as poor health can hinder their ability to fully dedicate themselves to national security (<xref ref-type="bibr" rid="ref3">3</xref>). This study represents a novel attempt to explore sex-based differences in early MetS detection among Air Force personnel via machine learning models. We systematically developed prediction models by sequentially incorporating demographic, anthropometric, clinical, lifestyle, mental health, and biochemical features. Six machine learning algorithms were employed, and the models were tailored by sex. Model performance and feature importance were subsequently evaluated.</p>
<p>Among the models, the LR model exhibited the most robust performance in predicting MetS, achieving an accuracy and AUC of 0.89. The RF model also performed well. The findings revealed that BMI, age, and ALT level were the three strongest predictors of MetS in Air Force personnel. For men, total cholesterol and uric acid were also key predictors, whereas hemoglobin and hematocrit were influential for women. These results emphasize the importance of tailoring early MetS risk detection models to account for sex-based differences.</p>
<p>Beyond model-derived predictors, our analysis of individual MetS components revealed a noteworthy sex-specific pattern in HDL-C abnormalities. Although the overall prevalence of reduced HDL-C was similar between men and women, within the MetS subgroup women were disproportionately more likely than men to exhibit reduced HDL-C. This observation aligns with findings from Ramezankhani et al., who reported that HDL-C decline was more strongly associated with MetS progression in women than in men (<xref ref-type="bibr" rid="ref27">27</xref>). While HDL-C was not included as a predictor variable in our models due to its role in defining the MetS outcome, the sex-specific distribution observed in our study underscores the importance of developing tailored prediction models that reflect distinct risk profiles in men and women.</p>
<p>Elevated ALT levels were consistently identified as a significant predictor of MetS in both sexes. ALT is a specific marker of liver function, as it is predominantly localized in hepatocytes and is released into the bloodstream following liver cell damage (<xref ref-type="bibr" rid="ref28">28</xref>). Its elevation is strongly linked to fatty liver disease, a condition that leads to lipid accumulation in the liver and other organs, ultimately promoting insulin resistance&#x2014;a key factor in the development and progression of MetS (<xref ref-type="bibr" rid="ref29">29</xref>). In contrast, AST reflects systemic enzymatic activity, as it is found in multiple tissues, including the heart, brain, and skeletal muscles, making it less specific to liver function. The liver-specific role of ALT in MetS development explains its stronger association with MetS than that of AST. Our findings align with those of previous studies conducted among military personnel, which reported the significance of ALT in MetS prediction (<xref ref-type="bibr" rid="ref30">30</xref>). Additionally, elevated ALT levels have been associated with occupational stress and fatigue, which are factors prevalent among military personnel (<xref ref-type="bibr" rid="ref31">31</xref>).</p>
<p>In our study, biochemical parameters exhibited greater specificity for MetS prediction than did disease-related and lifestyle factors. This may be attributed to the gradual emergence of biochemical abnormalities during the pathophysiological progression of MetS. Prioritizing these biochemical markers in screening processes can enhance early detection and improve intervention strategies for MetS. In contrast, disease-related and lifestyle factors, such as smoking and alcohol consumption, are well-established risks that indirectly contribute to biochemical changes leading to MetS (<xref ref-type="bibr" rid="ref32">32</xref>). This highlights the need for an integrated approach that combines biochemical monitoring with lifestyle interventions to provide comprehensive strategies for preventing and managing MetS.</p>
<p>Interestingly, mental health indicators were not identified as key predictors of MetS in this cohort. One possible explanation is the unique resilience and coping mechanisms instilled by military training, which may mitigate the impact of psychological stress on metabolic health (<xref ref-type="bibr" rid="ref33">33</xref>, <xref ref-type="bibr" rid="ref34">34</xref>). The strong emphasis on discipline, physical fitness, and mental toughness in military culture likely contributes to this resilience (<xref ref-type="bibr" rid="ref35">35</xref>). However, two alternative explanations should also be considered. First, military recruitment and retention policies generally exclude individuals with severe mental health conditions, leading to a more homogeneous cohort with less variability in psychological indicators. Secondly, reliance on self-reported measures of psychological distress may limit the ability to fully capture real-world mental health conditions. In particular, social desirability bias may have led participants to underreport BSRS-5 symptoms, potentially attenuating the observed associations with MetS and highlighting the need for further research and targeted intervention strategies.</p>
<p>This study has several limitations. First, the lack of genetic and dietary data limits the comprehensiveness of prediction models. The incorporation of such data in future studies may increase model accuracy. Second, because the study was conducted on Air Force personnel, the generalizability of the findings to other populations remains uncertain. Finally, feature importance was analyzed via cross-sectional data, which hindered the investigation of causal relationships between the features and MetS. Large-scale longitudinal studies must be conducted in the future.</p>
</sec>
<sec sec-type="conclusions" id="sec16">
<label>5</label>
<title>Conclusion</title>
<p>We developed sex-specific MetS prediction models for military personnel that incorporate demographic, anthropometric, clinical, lifestyle, mental, and biochemical features. The LR model achieved the highest accuracy and AUC for MetS prediction, followed closely by the RF model. BMI, age, and ALT level emerged as the most important predictors of MetS in both sexes. For men, total cholesterol and uric acid were also significant, whereas hemoglobin and hematocrit were influential for women. These findings highlight the importance of sex-based differences in early MetS risk detection and the utility of early prediction models in routine health screenings.</p>
<p>Based on these results, population-level interventions should emphasize structured weight management, education on liver health (e.g., reducing alcohol consumption and unhealthy diets), and age-specific health screenings for all personnel. For men, targeted strategies should include dietary modifications to lower total cholesterol and uric acid levels, combined with regular monitoring to enable early management of these risks. For women, interventions should prioritize nutritional support to maintain adequate hemoglobin and hematocrit levels, along with routine screening to detect and address underlying causes of deficiencies. Tailoring preventive strategies to sex-specific risk profiles may enhance early detection and optimize the management of MetS in military populations.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec17">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="sec18">
<title>Ethics statement</title>
<p>The studies involving humans were approved by Tri-Service General Hospital, Taiwan. The studies were conducted in accordance with the local legislation and institutional requirements. The ethics committee/institutional review board waived the requirement of written informed consent for participation from the participants or the participants&#x2019; legal guardians/next of kin because written informed consent was waived by the Institutional Review Board because the study involved secondary analysis of anonymized health data collected for routine occupational health surveillance, posed minimal risk to participants, and did not involve any direct interaction or intervention.</p>
</sec>
<sec sec-type="author-contributions" id="sec19">
<title>Author contributions</title>
<p>W-YW: Visualization, Methodology, Conceptualization, Writing &#x2013; original draft, Validation. Y-SW: Software, Data curation, Methodology, Writing &#x2013; original draft, Formal analysis, Visualization. YH: Conceptualization, Funding acquisition, Writing &#x2013; original draft, Project administration, Validation, Methodology. W-CT: Conceptualization, Supervision, Writing &#x2013; review &#x0026; editing, Methodology, Funding acquisition.</p>
</sec>
<sec sec-type="funding-information" id="sec20">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by grants from the Medical Affairs Bureau, Ministry of National Defense (MND), Taiwan (grant numbers: MND-MAB-D-112092, MND-MAB-D-113126, and MND-MAB-E-114228). The funder was not involved in the study design, data collection, data analysis and interpretation, writing of the manuscript, or decision to submit this article for publication.</p>
</sec>
<ack>
<p>The authors thank Shin Hong Lin, MD, previous Air Force Colonel and Chief, the Medical Affairs Section, the Office of the Inspector General, and Min-Hui Hsieh, Air Force Command Headquarters, the Ministry of National Defense, Taiwan, Wu-Chien Chien and Nien-Ting Kuo, National Defense Medical Center, and Hao-Yi Wu, Tri-Service General Hospital for their help throughout the research process.</p>
</ack>
<sec sec-type="COI-statement" id="sec21">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec22">
<title>Generative AI statement</title>
<p>The author(s) declare that no Gen AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="sec23">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec24">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fpubh.2025.1625461/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fpubh.2025.1625461/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.PDF" id="SM1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayden</surname><given-names>MR</given-names></name></person-group>. <article-title>Overview and new insights into the metabolic syndrome: risk factors and emerging variables in the development of type 2 diabetes and cerebrocardiovascular disease</article-title>. <source>Medicina</source>. (<year>2023</year>) <volume>59</volume>:<fpage>e561</fpage>. doi: <pub-id pub-id-type="doi">10.3390/medicina59030561</pub-id>, PMID: <pub-id pub-id-type="pmid">36984562</pub-id></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neeland</surname><given-names>IJ</given-names></name> <name><surname>Lim</surname><given-names>S</given-names></name> <name><surname>Tchernof</surname><given-names>A</given-names></name> <name><surname>Gastaldelli</surname><given-names>A</given-names></name> <name><surname>Rangaswami</surname><given-names>J</given-names></name> <name><surname>Ndumele</surname><given-names>CE</given-names></name> <etal/></person-group>. <article-title>Metabolic syndrome</article-title>. <source>Nat Rev Dis Primers</source>. (<year>2024</year>) <volume>10</volume>:<fpage>77</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41572-024-00563-5</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>WY</given-names></name> <name><surname>Li</surname><given-names>CH</given-names></name> <name><surname>Wu</surname><given-names>YS</given-names></name> <name><surname>Chien</surname><given-names>WC</given-names></name> <name><surname>Wang</surname><given-names>KY</given-names></name> <name><surname>Tzeng</surname><given-names>WC</given-names></name></person-group>. <article-title>Gender differences in the prevalence of metabolic syndrome among taiwanese air force personnel: a population-based study</article-title>. <source>J Cardiovasc Nurs</source>. (<year>2020</year>) <volume>35</volume>:<fpage>502</fpage>&#x2013;<lpage>11</lpage>. doi: <pub-id pub-id-type="doi">10.1097/JCN.0000000000000714</pub-id>, PMID: <pub-id pub-id-type="pmid">32732778</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>X</given-names></name> <name><surname>Yang</surname><given-names>S</given-names></name> <name><surname>Li</surname><given-names>S</given-names></name> <name><surname>Su</surname><given-names>M</given-names></name> <name><surname>Wang</surname><given-names>N</given-names></name> <name><surname>Chen</surname><given-names>Y</given-names></name> <etal/></person-group>. <article-title>Prevalences of metabolic syndrome and its sex-specific association with socioeconomic status in rural China: a cross-sectional study</article-title>. <source>BMC Public Health</source>. (<year>2021</year>) <volume>21</volume>:<fpage>2033</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12889-021-12074-z</pub-id>, PMID: <pub-id pub-id-type="pmid">34742269</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>HC</given-names></name> <name><surname>Wu</surname><given-names>YS</given-names></name> <name><surname>Tzeng</surname><given-names>WC</given-names></name> <name><surname>Wu</surname><given-names>HY</given-names></name> <name><surname>Lee</surname><given-names>PC</given-names></name> <name><surname>Wang</surname><given-names>WY</given-names></name></person-group>. <article-title>Sex differences in risk factors for metabolic syndrome in middle-aged and senior hospital employees: a population-based cohort study</article-title>. <source>BMC Public Health</source>. (<year>2023</year>) <volume>23</volume>:<fpage>587</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12889-023-15491-4</pub-id>, PMID: <pub-id pub-id-type="pmid">36991367</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JH</given-names></name> <name><surname>Kim</surname><given-names>BJ</given-names></name> <name><surname>Kang</surname><given-names>JG</given-names></name> <name><surname>Kim</surname><given-names>BS</given-names></name> <name><surname>Kang</surname><given-names>JH</given-names></name></person-group>. <article-title>Association between cigarette smoking and diabetes mellitus using two different smoking stratifications in 145 040 Korean individuals: self-reported questionnaire and urine cotinine concentrations</article-title>. <source>J Diabetes</source>. (<year>2019</year>) <volume>11</volume>:<fpage>232</fpage>&#x2013;<lpage>41</lpage>. doi: <pub-id pub-id-type="doi">10.1111/1753-0407.12837</pub-id>, PMID: <pub-id pub-id-type="pmid">30091285</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y</given-names></name> <name><surname>Ying</surname><given-names>YY</given-names></name> <name><surname>Li</surname><given-names>SX</given-names></name> <name><surname>Wang</surname><given-names>SJ</given-names></name> <name><surname>Gong</surname><given-names>QH</given-names></name> <name><surname>Li</surname><given-names>H</given-names></name></person-group>. <article-title>Association between alcohol consumption and metabolic syndrome among Chinese adults</article-title>. <source>Public Health Nutr</source>. (<year>2021</year>) <volume>24</volume>:<fpage>4582</fpage>&#x2013;<lpage>90</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S1368980020004449</pub-id>, PMID: <pub-id pub-id-type="pmid">33168121</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>J</given-names></name> <name><surname>Abshire</surname><given-names>DA</given-names></name> <name><surname>Heiney</surname><given-names>SP</given-names></name> <name><surname>Wirth</surname><given-names>MD</given-names></name></person-group>. <article-title>Acculturation, physical activity, and metabolic syndrome in Asian American adults</article-title>. <source>J Transcult Nurs</source>. (<year>2022</year>) <volume>33</volume>:<fpage>675</fpage>&#x2013;<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1177/10436596221114150</pub-id>, PMID: <pub-id pub-id-type="pmid">35924549</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>YC</given-names></name> <name><surname>Geng</surname><given-names>JH</given-names></name> <name><surname>Wu</surname><given-names>PY</given-names></name> <name><surname>Huang</surname><given-names>JC</given-names></name> <name><surname>Chen</surname><given-names>SC</given-names></name> <name><surname>Chang</surname><given-names>JM</given-names></name> <etal/></person-group>. <article-title>Betel nut chewing increases the risk of metabolic syndrome and its components in a large Taiwanese population follow-up study category: original investigation</article-title>. <source>Nutrients</source>. (<year>2022</year>) <volume>14</volume>:<fpage>1018</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu14051018</pub-id>, PMID: <pub-id pub-id-type="pmid">35267993</pub-id></citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carabello</surname><given-names>M</given-names></name> <name><surname>Wolfson</surname><given-names>JA</given-names></name></person-group>. <article-title>Mexican immigrant health advantage in metabolic syndrome? Examining the contributions of demographic, socioeconomic, and health behavior characteristics</article-title>. <source>SSM Popul Health</source>. (<year>2021</year>) <volume>16</volume>:<fpage>100932</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ssmph.2021.100932</pub-id>, PMID: <pub-id pub-id-type="pmid">34786450</pub-id></citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chait</surname><given-names>A</given-names></name> <name><surname>den Hartigh</surname><given-names>LJ</given-names></name></person-group>. <article-title>Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease</article-title>. <source>Front Cardiovasc Med</source>. (<year>2020</year>) <volume>7</volume>:<fpage>22</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcvm.2020.00022</pub-id>, PMID: <pub-id pub-id-type="pmid">32158768</pub-id></citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tzeng</surname><given-names>WC</given-names></name> <name><surname>Chiang</surname><given-names>YS</given-names></name> <name><surname>Feng</surname><given-names>HP</given-names></name> <name><surname>Chien</surname><given-names>WC</given-names></name> <name><surname>Tai</surname><given-names>YM</given-names></name> <name><surname>Chen</surname><given-names>MJ</given-names></name></person-group>. <article-title>Gender differences in metabolic syndrome risk factors among patients with serious mental illness</article-title>. <source>Int J Ment Health Nurs</source>. (<year>2020</year>) <volume>29</volume>:<fpage>254</fpage>&#x2013;<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.1111/inm.12670</pub-id>, PMID: <pub-id pub-id-type="pmid">31670454</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gesteiro</surname><given-names>E</given-names></name> <name><surname>Meg&#x00ED;a</surname><given-names>A</given-names></name> <name><surname>Guadalupe-Grau</surname><given-names>A</given-names></name> <name><surname>Fernandez-Veledo</surname><given-names>S</given-names></name> <name><surname>Vendrell</surname><given-names>J</given-names></name> <name><surname>Gonz&#x00E1;lez-Gross</surname><given-names>M</given-names></name></person-group>. <article-title>Early identification of metabolic syndrome risk: a review of reviews and proposal for defining pre-metabolic syndrome status</article-title>. <source>Nutr Metab Cardiovasc Dis</source>. (<year>2021</year>) <volume>31</volume>:<fpage>2557</fpage>&#x2013;<lpage>74</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.numecd.2021.05.022</pub-id>, PMID: <pub-id pub-id-type="pmid">34244048</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>YS</given-names></name> <name><surname>Tzeng</surname><given-names>WC</given-names></name> <name><surname>Chu</surname><given-names>CM</given-names></name> <name><surname>Wang</surname><given-names>WY</given-names></name></person-group>. <article-title>Metabolic syndrome and its related factors among hospital employees: a population-based cohort study</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2021</year>) <volume>18</volume>:<fpage>9826</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph18189826</pub-id>, PMID: <pub-id pub-id-type="pmid">34574750</pub-id></citation></ref>
<ref id="ref15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moradi</surname><given-names>M</given-names></name> <name><surname>Ghadiri</surname><given-names>N</given-names></name></person-group>. <article-title>Different approaches for identifying important concepts in probabilistic biomedical text summarization</article-title>. <source>Artif Intell Med</source>. (<year>2018</year>) <volume>84</volume>:<fpage>101</fpage>&#x2013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.artmed.2017.11.004</pub-id>, PMID: <pub-id pub-id-type="pmid">29208328</pub-id></citation></ref>
<ref id="ref16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>LE</given-names></name></person-group>. <article-title>K-nearest neighbor</article-title>. <source>Scholarpedia</source>. (<year>2009</year>) <volume>4</volume>:<fpage>e1883</fpage>. doi: <pub-id pub-id-type="doi">10.4249/scholarpedia.1883</pub-id></citation></ref>
<ref id="ref17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Popchev</surname><given-names>I</given-names></name> <name><surname>Daniela</surname><given-names>O</given-names></name></person-group>. <article-title>Multi-step methods for machine learning models with web metrics</article-title>. <source>Proceed Bulgarian Acad Sci</source>. (<year>2023</year>) <volume>76</volume>:<fpage>1707</fpage>&#x2013;<lpage>16</lpage>. doi: <pub-id pub-id-type="doi">10.7546/CRABS.2023.11.08</pub-id></citation></ref>
<ref id="ref18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choe</surname><given-names>EK</given-names></name> <name><surname>Rhee</surname><given-names>H</given-names></name> <name><surname>Lee</surname><given-names>S</given-names></name> <name><surname>Shin</surname><given-names>E</given-names></name> <name><surname>Oh</surname><given-names>SW</given-names></name> <name><surname>Lee</surname><given-names>JE</given-names></name> <etal/></person-group>. <article-title>Metabolic syndrome prediction using machine learning models with genetic and clinical information from a nonobese healthy population</article-title>. <source>Genomics Inform</source>. (<year>2018</year>) <volume>16</volume>:<fpage>e31</fpage>. doi: <pub-id pub-id-type="doi">10.5808/GI.2018.16.4.e31</pub-id>, PMID: <pub-id pub-id-type="pmid">30602092</pub-id></citation></ref>
<ref id="ref19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name> <name><surname>Lee</surname><given-names>H</given-names></name> <name><surname>Choi</surname><given-names>JR</given-names></name> <name><surname>Koh</surname><given-names>SB</given-names></name></person-group>. <article-title>Development and validation of prediction model for risk reduction of metabolic syndrome by body weight control: a prospective population-based study</article-title>. <source>Sci Rep</source>. (<year>2020</year>) <volume>10</volume>:<fpage>10006</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-020-67238-5</pub-id>, PMID: <pub-id pub-id-type="pmid">32561810</pub-id></citation></ref>
<ref id="ref20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JE</given-names></name> <name><surname>Mun</surname><given-names>S</given-names></name> <name><surname>Lee</surname><given-names>S</given-names></name></person-group>. <article-title>Metabolic syndrome prediction models using machine learning and sasang constitution type</article-title>. <source>Evid Based Complement Alternat Med</source>. (<year>2021</year>) <volume>2021</volume>:<fpage>8315047</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2021/8315047</pub-id>, PMID: <pub-id pub-id-type="pmid">33628316</pub-id></citation></ref>
<ref id="ref21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eyvazlou</surname><given-names>M</given-names></name> <name><surname>Hosseinpouri</surname><given-names>M</given-names></name> <name><surname>Mokarami</surname><given-names>H</given-names></name> <name><surname>Gharibi</surname><given-names>V</given-names></name> <name><surname>Jahangiri</surname><given-names>M</given-names></name> <name><surname>Cousins</surname><given-names>R</given-names></name> <etal/></person-group>. <article-title>Prediction of metabolic syndrome based on sleep and work-related risk factors using an artificial neural network</article-title>. <source>BMC Endocr Disord</source>. (<year>2020</year>) <volume>20</volume>:<fpage>169</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12902-020-00645-x</pub-id>, PMID: <pub-id pub-id-type="pmid">33183282</pub-id></citation></ref>
<ref id="ref22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grundy</surname><given-names>SM</given-names></name> <name><surname>Cleeman</surname><given-names>JI</given-names></name> <name><surname>Daniels</surname><given-names>SR</given-names></name> <name><surname>Donato</surname><given-names>KA</given-names></name> <name><surname>Eckel</surname><given-names>RH</given-names></name> <name><surname>Franklin</surname><given-names>BA</given-names></name> <etal/></person-group>. <article-title>Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement</article-title>. <source>Circulation</source>. (<year>2005</year>) <volume>112</volume>:<fpage>2735</fpage>&#x2013;<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.169404</pub-id>, PMID: <pub-id pub-id-type="pmid">16157765</pub-id></citation></ref>
<ref id="ref23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>MB</given-names></name> <name><surname>Liao</surname><given-names>SC</given-names></name> <name><surname>Lee</surname><given-names>YJ</given-names></name> <name><surname>Wu</surname><given-names>CH</given-names></name> <name><surname>Tseng</surname><given-names>MC</given-names></name> <name><surname>Gau</surname><given-names>SF</given-names></name> <etal/></person-group>. <article-title>Development and verification of validity and reliability of a short screening instrument to identify psychiatric morbidity</article-title>. <source>J Formos Med Assoc</source>. (<year>2003</year>) <volume>102</volume>:<fpage>687</fpage>&#x2013;<lpage>94</lpage>.</citation></ref>
<ref id="ref24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lung</surname><given-names>FW</given-names></name> <name><surname>Lee</surname><given-names>MB</given-names></name></person-group>. <article-title>The five-item brief-symptom rating scale as a suicide ideation screening instrument for psychiatric inpatients and community residents</article-title>. <source>BMC Psychiatry</source>. (<year>2008</year>) <volume>8</volume>:<fpage>53</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-244X-8-53</pub-id>, PMID: <pub-id pub-id-type="pmid">18597675</pub-id></citation></ref>
<ref id="ref25"><label>25.</label><citation citation-type="other"><person-group person-group-type="author"><collab id="coll1">Health Promotion Administration, Taiwan</collab></person-group>. Diagnostic criteria of metabolic syndrome in Taiwan. (<year>2007</year>) Available online at: <ext-link xlink:href="https://www.hpa.gov.tw/Pages/EBook.aspx?nodeid=1175" ext-link-type="uri">https://www.hpa.gov.tw/Pages/EBook.aspx?nodeid=1175</ext-link> (accessed May 12, 2023).</citation></ref>
<ref id="ref26"><label>26.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>A</given-names></name> <name><surname>Garcia</surname><given-names>S</given-names></name> <name><surname>Herrera</surname><given-names>F</given-names></name> <name><surname>Chawla</surname><given-names>NV</given-names></name></person-group>. <article-title>Smote for learning from imbalanced data: progress and challenges, marking the 15-year anniversary</article-title>. <source>J Artif Intell Res</source>. (<year>2018</year>) <volume>61</volume>:<fpage>863</fpage>&#x2013;<lpage>905</lpage>. doi: <pub-id pub-id-type="doi">10.1613/jair.1.11192</pub-id></citation></ref>
<ref id="ref27"><label>27.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramezankhani</surname><given-names>A</given-names></name> <name><surname>Azizi</surname><given-names>F</given-names></name> <name><surname>Hadaegh</surname><given-names>F</given-names></name></person-group>. <article-title>Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study</article-title>. <source>Cardiovasc Diabetol</source>. (<year>2022</year>) <volume>21</volume>:<fpage>227</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12933-022-01665-8</pub-id>, PMID: <pub-id pub-id-type="pmid">36324143</pub-id></citation></ref>
<ref id="ref28"><label>28.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thakur</surname><given-names>S</given-names></name> <name><surname>Kumar</surname><given-names>V</given-names></name> <name><surname>Das</surname><given-names>R</given-names></name> <name><surname>Sharma</surname><given-names>V</given-names></name> <name><surname>Mehta</surname><given-names>DK</given-names></name></person-group>. <article-title>Biomarkers of hepatic toxicity: an overview</article-title>. <source>Curr Ther Res Clin Exp</source>. (<year>2024</year>) <volume>100</volume>:<fpage>100737</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.curtheres.2024.100737</pub-id>, PMID: <pub-id pub-id-type="pmid">38860148</pub-id></citation></ref>
<ref id="ref29"><label>29.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zohara</surname><given-names>Z</given-names></name> <name><surname>Adelekun</surname><given-names>A</given-names></name> <name><surname>Seffah</surname><given-names>KD</given-names></name> <name><surname>Salib</surname><given-names>K</given-names></name> <name><surname>Dardari</surname><given-names>L</given-names></name> <name><surname>Taha</surname><given-names>M</given-names></name> <etal/></person-group>. <article-title>The prospect of non-alcoholic fatty liver disease in adult patients with metabolic syndrome: a systematic review</article-title>. <source>Cureus</source>. (<year>2023</year>) <volume>15</volume>:<fpage>e41959</fpage>. doi: <pub-id pub-id-type="doi">10.7759/cureus.41959</pub-id></citation></ref>
<ref id="ref30"><label>30.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>C</given-names></name> <name><surname>Kim</surname><given-names>J</given-names></name> <name><surname>Kim</surname><given-names>JY</given-names></name> <name><surname>Chang</surname><given-names>E</given-names></name> <name><surname>Park</surname><given-names>SY</given-names></name> <name><surname>Lee</surname><given-names>W</given-names></name> <etal/></person-group>. <article-title>Clinical markers associated with metabolic syndrome among military aviators</article-title>. <source>Aerosp Med Hum Perform</source>. (<year>2015</year>) <volume>86</volume>:<fpage>970</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.3357/AMHP.4362.2015</pub-id>, PMID: <pub-id pub-id-type="pmid">26564762</pub-id></citation></ref>
<ref id="ref31"><label>31.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>KW</given-names></name> <name><surname>Meng</surname><given-names>FC</given-names></name> <name><surname>Shih</surname><given-names>YL</given-names></name> <name><surname>Su</surname><given-names>FY</given-names></name> <name><surname>Lin</surname><given-names>YP</given-names></name> <name><surname>Lin</surname><given-names>F</given-names></name> <etal/></person-group>. <article-title>Sex-specific association between metabolic abnormalities and elevated alanine aminotransferase levels in a military cohort: the CHIEF study</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2018</year>) <volume>15</volume>:<fpage>545</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph15030545</pub-id>, PMID: <pub-id pub-id-type="pmid">29562671</pub-id></citation></ref>
<ref id="ref32"><label>32.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N</given-names></name> <name><surname>Liu</surname><given-names>X</given-names></name> <name><surname>Wang</surname><given-names>L</given-names></name> <name><surname>Zhang</surname><given-names>Y</given-names></name> <name><surname>Xiang</surname><given-names>Y</given-names></name> <name><surname>Cai</surname><given-names>J</given-names></name> <etal/></person-group>. <article-title>Lifestyle factors and their relative contributions to longitudinal progression of cardio-renal-metabolic multimorbidity: a prospective cohort study</article-title>. <source>Cardiovasc Diabetol</source>. (<year>2024</year>) <volume>23</volume>:<fpage>265</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12933-024-02347-3</pub-id>, PMID: <pub-id pub-id-type="pmid">39026309</pub-id></citation></ref>
<ref id="ref33"><label>33.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gifford</surname><given-names>RM</given-names></name> <name><surname>O'Leary</surname><given-names>TJ</given-names></name> <name><surname>Double</surname><given-names>RL</given-names></name> <name><surname>Wardle</surname><given-names>SL</given-names></name> <name><surname>Wilson</surname><given-names>K</given-names></name> <name><surname>Boyle</surname><given-names>LD</given-names></name> <etal/></person-group>. <article-title>Positive adaptation of HPA axis function in women during 44 weeks of infantry-based military training</article-title>. <source>Psychoneuroendocrinology</source>. (<year>2019</year>) <volume>110</volume>:<fpage>104432</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.psyneuen.2019.104432</pub-id>, PMID: <pub-id pub-id-type="pmid">31536944</pub-id></citation></ref>
<ref id="ref34"><label>34.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Westphal</surname><given-names>RJ</given-names></name> <name><surname>Convoy</surname><given-names>SP</given-names></name></person-group>. <article-title>Military culture implications for mental health and nursing care</article-title>. <source>Online J Issues Nurs</source>. (<year>2015</year>) <volume>20</volume>:<fpage>4</fpage>. doi: <pub-id pub-id-type="doi">10.3912/OJIN.Vol20No01Man04</pub-id></citation></ref>
<ref id="ref35"><label>35.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taylor-Clark</surname><given-names>TM</given-names></name> <name><surname>Patrician</surname><given-names>PA</given-names></name></person-group>. <article-title>Soldier-centered care: a concept analysis</article-title>. <source>Mil Med</source>. (<year>2020</year>) <volume>185</volume>:<fpage>e422</fpage>&#x2013;<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1093/milmed/usz448</pub-id>, PMID: <pub-id pub-id-type="pmid">31942626</pub-id></citation></ref>
</ref-list>
</back>
</article>